Engineering extracellular matrix-based hydrogels for intervertebral disc regeneration.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedics

Background:

• Lower back pain (LBP) is a significant health issue, particularly in older adults.
• Intervertebral disc (IVD) degeneration, driven by extracellular matrix (ECM) dysregulation and inflammation, is a primary cause of LBP.
• Regenerative therapies offer potential for restoring IVD function by addressing these biological alterations.

Purpose of the Study:

• To provide a comprehensive review of IVD anatomy, physiology, and the degenerative process.
• To discuss current LBP management strategies for IVD degeneration.
• To highlight advancements in hydrogel engineering for ECM-targeted regenerative therapy in IVD degeneration.

Main Methods:

• Review of existing literature on IVD biology, degeneration, and regenerative therapies.
• Focus on hydrogel materials (natural, synthetic, composite) and their properties.
• Analysis of innovations in hydrogel crosslinking and degradation for IVD regeneration.

Main Results:

• Hydrogels engineered for ECM-targeting show potential in regenerative therapy for IVD degeneration.
• Innovations in hydrogel technology, including crosslinking and degradation control, can enhance IVD regeneration.
• Hydrogel-based ECM mimics offer biomimetic properties for effective LBP management.

Conclusions:

• Hydrogel-based ECM mimics represent a promising strategy for developing durable therapies for IVD degeneration.
• These advanced materials can address the root causes of disc degeneration, offering new hope for chronic LBP patients.
• Further advancements in hydrogel technology could significantly improve LBP management through enhanced IVD regeneration.